Comment on

• Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.

  Miyamoto Y, Oho K, Kumamoto M, Toyonaga A, Sata M. Miyamoto Y, et al. J Gastroenterol Hepatol. 2003 Aug;18(8):934-42. doi: 10.1046/j.1440-1746.2003.03087.x. J Gastroenterol Hepatol. 2003. PMID: 12859723
• Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience.

  Akahoshi T, Hashizume M, Tomikawa M, Kawanaka H, Yamaguchi S, Konishi K, Kinjo N, Maehara Y. Akahoshi T, et al. J Gastroenterol Hepatol. 2008 Nov;23(11):1702-9. doi: 10.1111/j.1440-1746.2008.05549.x. Epub 2008 Aug 17. J Gastroenterol Hepatol. 2008. PMID: 18713295
• Management of gastric varices.

  Hashizume M, Akahoshi T, Tomikawa M. Hashizume M, et al. J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:102-8. doi: 10.1111/j.1440-1746.2010.06572.x. J Gastroenterol Hepatol. 2011. PMID: 21199520 Review.
• Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration: relation to hepatic vein pressure gradient.

  Uehara H, Akahoshi T, Tomikawa M, Kinjo N, Hashimoto N, Nagao Y, Kamori M, Maehara Y. Uehara H, et al. J Gastroenterol Hepatol. 2012 Jan;27(1):137-41. doi: 10.1111/j.1440-1746.2011.06835.x. J Gastroenterol Hepatol. 2012. PMID: 21722180